Scope of nanotechnology-based radiation therapy and thermotherapy methods in cancer treatment

Current Cancer Drug Targets

Volumn 12, Issue 8, 2012, Pages 998-1015

  Bakht, Mohamadreza K ^a   Sadeghi, Mahdi ^b   Pourbaghi Masouleh, Milad ^c   Tenreiro, Claudio ^d,e  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b AGRICULTURAL MEDICAL AND INDUSTRIAL RESEARCH SCHOOL   (Iran)

^c Nanotechnology and Advanced Materials Department   (Iran)

^d Sungkyunkwan University   (South Korea)

^e UNIVERSIDAD DE TALCA   (Chile)

Author keywords

Cancer treatment; Nanotechnology; Radiation therapy; Thermotherapy

Indexed keywords

ARSENIC ACID; CADMIUM; CARBON NANOTUBE; COLLOIDAL GOLD; COMPLEMENTARY RNA; CONTRAST MEDIUM; DENDRIMER; GALLIUM; GOLD NANOPARTICLE; INDIUM; IRON OXIDE; LIPOSOME; MACROGOL; MAGNETIC NANOPARTICLE; MONOCLONAL ANTIBODY; MULTI WALLED NANOTUBE; NANOCRYSTAL; NANOPARTICLE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; NUCLEIC ACID; QUANTUM DOT; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; SELENIUM; SILVER NANOPARTICLE; SINGLE WALLED NANOTUBE; SMALL INTERFERING RNA; TELLURIUM; UNINDEXED DRUG; ZINC SULFIDE;

CANCER CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; COLLOID; CONTRAST ENHANCEMENT; DNA DAMAGE; DRUG DELIVERY SYSTEM; DRUG TARGETING; GENE TRANSFER; HUMAN; HYPERTHERMIC THERAPY; IONIZING RADIATION; LYMPH NODE; MAGNETIC FIELD; MOLECULARLY TARGETED THERAPY; NANOMEDICINE; NANOTECHNOLOGY; NEUTRON CAPTURE THERAPY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; RADIOFREQUENCY ABLATION; REVIEW;

CHEMORADIOTHERAPY; HUMANS; HYPERTHERMIA, INDUCED; METALS, HEAVY; NANOMEDICINE; NANOPARTICLES; NEOPLASMS; PHOTOCHEMOTHERAPY; QUANTUM DOTS; RADIOISOTOPES;

EID: 84867755015     PISSN: 15680096     EISSN: 18735576     Source Type: Journal    
DOI: 10.2174/156800912803251216     Document Type: Review

References (237)

1. American Cancer Society. Cancer Facts & Figures 2012. http://www.cancer.org/acs/groups/content/@epidemiologysurveilan ce/documents/document/acspc-031941.pdf (Accessed January, 2012).
2. Misra, R.; Acharya, S.; Sahoo, S. K. Cancer nanotechnology: application of nanotechnology in cancer therapy: Drug. Discov. Today 2010, 15, 842-850.
3. Sadeghi, M.; Enferadi. M.; Shirazi, A. External and internal radiation therapy: past and future directions. J. Cancer Res. Ther. 2010, 6, 239-248.
4. Symonds, R. P.; Foweraker, K. Principles of chemotherapy and radiotherapy. Curr. Obstet. Gynaecol. 2006, 16, 100-106.
5. Lammers, T. Improving the efficacy of combined modality anticancer therapy using HPMA copolymer-based nanomedicine formulations. Adv. Drug. Del. Rev. 2010, 62, 203-230.
6. Wang, X.; Yang, L.; Chen, Z. G.; Shin, D. M. Application of nanotechnology in cancer therapy and imaging. CA Cancer. J. Clin. 2008, 58, 97-110.
7. Poizot, P.; Laruelle, S.; Grugeon, S.; Dupont, L.; Tarascon, J. M. Nano-sized transition-metal oxides as negative-electrode materials for lithium-ion batteries. Nature 2000, 407, 496-499.
8. Egorov, F.; Potapov, V.; Fiber-optic sensors based on fiber-optic lasers and microoptomechanical resonance structures. Laser Phys. 2011, 21, 299-303.
9. Mahmoudi, M.; Simchi, A.; Imani, M.; Stroeve, P.; Sohrabi, A. Templated growth of superparamagnetic iron oxide nanoparticles by temperature programming in the presence of poly(vinyl alcohol). Thin Solid Films 2010, 518, 4281-4289.
10. Davis, M. E.; Chen, Z. G.; Shin, D. M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug. Discov. 2008, 7, 771-782.
11. Bawarski, W. E.; Chidlowsky, E.; Bharali, D. J.; Mousa, S. A. Emerging nanopharmaceuticals. Nanomedicine 2008, 4, 273-282.
12. Sanhai, W. R.; Sakamoto, J. H.; Canady, R.; Ferrari, M. Seven challenges for nanomedicine. Nat. Nanotechnol. 2008, 3, 242-244.
13. Ferrari, M. Cancer nanotechnology: opportunities and challenges. Nat. Rev. Cancer 2005, 5, 161-171.
14. Rivera Gil, P.; Hühn, D.; Del Mercato, L. L.; Sasse, D.; Parak, W. J. Nanopharmacy: Inorganic nanoscale devices as vectors and active compounds. Pharmacol. Res. 2010, 62, 115-125.
15. Lammers, T.; Hennink, W. E.; Storm, G. Tumor-targeted nanomedicines: principles and practice. Brit. J. Cancer 2008, 99, 392-397.
16. Thassu, D.; Deleers, M.; Pathak, Y. Nanoparticulate Drug Delivery Systems, 1st ed.; Informa Healthcare; New York, 2007.
17. Wang, A. Z.; Gu, F. X.; Farokhzad O. C. In: Safety of Nanoparticles From Manufacturing to Medical Applications; Webster, T. J.; Springer: New York, 2009; pp. 209-235
18. Brown D. M. Drug Delivery Systems in Cancer Therapy, 3rd ed.; Humana press: New Jersey, 2003.
19. Khan, F. Handbook of the physics of radiation therapy. 4th ed.; Williams and Wilkins: Baltimore, 2009.
20. Mesbahi, A. A review on gold nanoparticles radiosensitization effect in radiation therapy of cancer. Rep. Pract. Oncol. Radiothe. 2010, 15, 176-180.
21. Bakht, M. K.; Sadeghi, M. Internal radiotherapy techniques using radiolanthanide praseodymium-142: a review of production routes, brachytherapy, unsealed source therapy. Ann. Nucl. Med. 2011, 25, 529-535.
22. Sadeghi, M.; Bakht M. K.; Mokhtari, L. Practicality of the cyclotron production of radiolanthanide 142Pr: a potential for therapeutic applications and biodistribution studies. J. Radioanal. Nucl. Chem. 2011, 288, 937-942.
23. Bakht M. K.; Jabal-Ameli, H.; Ahmadi, S.J.; Sadeghi, M.; Sadjadi, S.S.; Tenreiro, C. Bremsstrahlung parameters of praseodymium-142 in different human tissues: a dosimetric perspective for 142Pr radionuclide therapy, Ann. Nucl. Med. In press. DOI: 10.1007/s12149-012-0591-6
24. Thisgaard, H. Accelerator based production of Auger electron emitting isotopes for radionuclide therapy. PhD Thesis, University of Copenhagen: Denmark, Copenhagen, August 2008.
25. O'Donnell, R. T. Nuclear localizing sequences: an innovative way to improve targeted radiotherapy. J. Nucl. Med. 2006, 47, 738-739.
26. Flower, M. A. Targeted radiotherapy review meeting. Report on a meeting organized by the BIR Nuclear Medicine Committee and the IPEM Radionuclide Special Interest Group, held at the British Institute of Li, S.; Beheshti, M. The radionuclide molecular imaging and therapy of neuroendocrine tumors. Curr. Cancer Drug Tar. 2005, 5, 139-148.
27. Ting, G.; Chang, C. H.; Wang, H. E.; Lee, T. W. Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy. J. Biomed. Biotechnol. 2010, ID 953537.
28. Torchilin, V. P. Recent advances with liposomes as pharmaceutical carriers. Nat. Rev. Drug. Discov. 2005, 4,145-160.
29. Lee, J. D.; Ueno, M.; Miyajima, Y.; Nakamura, H. Synthesis of boron cluster lipids: closo-dodecaborate as an alternative hydrophilic function of boronated liposomes for neutron capture therapy. Org. Lett. 2007, 9, 323-326.
30. Amirfazli, A. Nanomedicine: magnetic nanoparticles hit the target. Nat. Nanotechnol. 2007, 2, 467-468.
31. Reilly, R. M. Carbon Nanotubes: Potential benefits and risks of nanotechnology in nuclear medicine. J. Nucl. Med. 2007, 48, 1039-1042.
32. Cheng, K. T.; McDevitt, M. R.; Scheinberg, D. A. Single-walled carbon nanotubes-111In-1,4,7,10-tetraazacyclododecane-N, N′, N″, N‴-tetraacetic acid-rituximab. http://www.ncbi.nlm.nih.gov/books/ NBK23572/pdf/CNT-rituximab111In.pdf (Access August 3, 2010).
33. Torchilin, V. P. PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv. Drug. Deliv. Rev. 2002, 54, 235-252.
34. Kobayashi, H.; Wu, C.; Kim, M. K.; Paik, C. H.; Carrasquillo, J. A.; Brechbiel, M. W. Evaluation of the in vivo biodistribution of indium-111 and yttrium-88 labeled dendrimer-1B4M-DTPA. Bioconjug. Chem. 1999, 10, 103-111.
35. Patri, A. K.; Kukowska-Latallo, J. F.; Baker, J. R. Jr. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non-covalent drug inclusion complex. Adv. Drug. Deliv. Rev. 2005, 57, 2203-2214.
36. Azhdarinia, A.; Yang, D. J.; Yu, D. F.; Mendez, R.; Oh, C.; Kohanim, S.; Bryant, J.; Kim, E. E. Regional Radiochemotherapy Using In Situ Hydrogel. Pharm. Res. 2005, 22, 776-783.
37. Peppas, N. A.; Hilt, J. Z.; Khademhosseini, A.; Langer, R. Hydrogels in biology and medicine: from molecular principles to bionanotechnology. Adv. Mater. 2006, 18, 1345-1360.
38. Azab, A. K.; Kleinstern, J.; Doviner, V.; Orkin, B.; Srebnik, M.; Nissan, A.; Rubinstein, A. Prevention of tumor recurrence and distant metastasis formation in a breast cancer mouse model by biodegradable implant of 131I-norcholesterol. J. Control. Release 2007, 123, 116-122.
39. Rai, P.; Mallidi, S.; Zheng, X.; Rahmanzadeh, R.; Mir, Y.; Elrington, S.; Khurshid, A.; Hasan, T. Development and applications of photo-triggered theranostic agents. Adv. Drug. Deliv. Rev. 2010, 62, 1094-1124.
40. Bakht, M. K.; Sadeghi, M.; Tenreiro, C. A novel technique for simultaneous diagnosis and radioprotection by radioactive cerium oxide nanoparticles: study of cyclotron production of 137mCe. J. Radioanalytical. Nucl. Chem. 2012, 292, 53-59.
41. Jokerst, J. V.; Gambhir, S. S. Molecular Imaging with theranostic nanoparticles. Acc. Chem. Res. 2011, 44, 1050-1060.
42. Ma, X.; Zhao, Y.; Liang, X. J. Theranostic nanoparticles engineered for clinic and pharmaceutics. Acc. Chem. Res. 2011, 44, 1114-1122.
43. Chen, X.; Gambhir, S.S.; Cheon, J. Theranostic nanomedicine. Acc. Chem. Res. 2011, 44, 841.
44. Kucka, J.; Hruby, M.; Konák, C.; Kozempel, J.; Lebeda, O. Astatination of nanoparticles containing silver as possible carriers of 211At. Appl. Radiat. Isotopes 2006, 64, 201-206.
45. Jonasdottir, T. J.; Fisher, D. R.; Borrebaek, J.; Bruland, O. S.; Larsen, R. H. First in vivo evaluation of liposome-encapsulated 223Ra as a potential alpha-particle-emitting cancer therapeutic agent. Anticancer Res. 2006, 26, 2841-2848.
46. Sofou, S.; Thomas, J. L.; Lin, H. Y.; McDevitt, M. R.; Scheinberg, D. A.; Sgouros, G. Engineered liposomes for potential alphaparticle therapy of metastatic cancer. J. Nucl. Med. 2004, 45, 253-260.
47. Sofou, S.; Kappel, B. J.; Jaggi, J. S.; McDevitt, M. R.; Scheinberg, D. A.; Sgouros, G. Enhanced retention of the alpha-particle emitting daughters of actinium-225 by liposome carriers. Bioconjug. Chem. 2007, 18, 2061-2067.
48. Kaspersen, F. M.; Bos, E.; Doornmalen, A. V.; Geerlings, M. W.; Apostolidis, C.; Molinet, R. Cytotoxicity of 213Bi-and 225Acimmunoconjugates. Nucl. Med. Commun. 1995, 16, 468-476.
49. Chappell, L. L.; Deal, K. A.; Dadachova, E.; Brechbiel, M. W. Synthesis, conjugation, and radiolabeling of a novel bifunctional chelating agent for 225Ac radioimmunotherapy applications. Bioconjug. Chem. 2000, 11, 510-519.
50. Kennel, S. J.; Chappell, L. L.; Dadachova, K.; Brechbiel, M. W.; Lankford, T. K.; Davis, I. A.; Stabin, M.; Mirzadeh, M. Evaluation of 225Ac for vascular targeted radioimmunotherapy of lung tumors. Cancer. Biother. Radiopharm. 2000, 15, 235-244.
51. Borchardt, P. E.; Yuan, R. R.; Miederer, M.; McDevitt, M. R.; Scheinberg, D. A. Targeted actinium-225 in vivo generators for therapy of ovarian cancer. Cancer Res. 2003, 63, 5084-5090.
52. Miederer, M.; McDevitt, M. R.; Sgouros, G.; Kramer, K.; Cheung, N. K.; Scheinberg, D. A. Pharmacokinetics, dosimetry, and toxicity of the targetable atomic generator, 225Ac-HuM195, in nonhuman primates. J. Nucl. Med. 2004, 45, 129-137.
53. Miederer, M.; Scheinberg, D. A.; McDevitt, M. R. Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications. Adv. Drug Deliv. Rev. 2008, 60, 1371-1382.
54. Häfeli, U.; Tiefenauer, L. X.; Schbiger, P. A.; Weder, H. G. A lipophilic complex with 186Re/188Re incorporated in liposomes suitable for radiotherapy. Int. J. Rad. Appl. Instrum. B 1991, 18, 449-454.
55. Bao, A.; Goins, B.; Klipper, R.; Negrete, G.; Mahindaratne, M.; Phillips, W. T. A novel liposome radiolabeling method using 99mTc-"SNS/S" complexes: in vitro and in vivo evaluation. J. Pharm. Sci. 2003, 92, 1893-1904.
56. Chang, Y. J.; Chang, C. H.; Chang, T. J.; Yu, C. Y.; Chen, L. C.; Jan, M. L.; Luo, T. Y.; Lee, T. W.; Ting, G. Biodistribution, pharmacokinetics and microSPECT/CT imaging of 188Re-BMEDAliposome in a C26 murine colon carcinoma solid tumor animal model. Anticancer. Res. 2007, 27, 2217-2225.
57. Liang, S.; Wang, Y.; Yu, J.; Zhang, C.; Xia, J.; Yin, D. Surface modified superparamagnetic iron oxide nanoparticles: as a new carrier for bio-magnetically targeted therapy. J. Mater. Sci. Mater. Med. 2007, 18, 2297-2302.
58. Hamoudeh, M.; Fessi, H.; Mehier, H.; Faraj, A. A.; Canet-Soulas, E. Dirhenium decacarbonyl-loaded PLLA nanoparticles: influence of neutron irradiation and preliminary in vivo administration by the TMT technique. Int. J. Pharm. 2008, 348, 125-36.
59. Hamoudeh, M.; Salim, H.; Barbos, D.; Paunoiu, C.; Fressi, H. Preparation and characterization of radioactive dirhenium decacarbonyl-loaded PLLA nanoparticles for radionuclide intratumoral therapy. Eur. J. Pharm. Biopharm. 2007, 67, 597-611.
60. Li, L.; Wartchow, C. A.; Danthi, S. N.; Shen, Z.; Dechene, N.; Pease, J.; Choi, H. S.; Doede, T.; Chu, P.; Ning, S.; Lee, D. Y.; Bednarski, M. D.; Knox, S. J. A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Ylabeled nanoparticles. Int. J. Radia. Oncol. Biol. Phys. 2004, 58, 1215-1227.
61. Emfietzoglou, D.; Bousis, C.; Hindorf, C.; Fotopoulos, A.; Pathak, A.; Kostarelos, K. A Monte Carlo study of energy deposition at the sub-cellular level for application to targeted radionuclide therapy with low-energy electron emitters. Nucl. Instrum. Meth. B 2007, 256, 547-553.
62. Cai, W.; Niu, G.; Chen, X. Imaging of integrins as biomarkers for tumor angiogenesis. Curr. Pharm. Des. 2008, 14, 2943-2973.
63. Cai, W.; Chen, X. Multimodality imaging of vascular endothelial growth factor and vascular endothelial growth factor receptor expression. Front. Biosci. 2007, 12, 4267-4279.
64. Dong, S.; Huang, G.; Liu, P.; Ma, Y.; Yan, W.; Wan, L.; Zhu, C. Efficacy and safety of 32P-nanocolloid for treatment of distant lymph node metastasis in VX2 tumor-bearing rabbits. Ann. Nucl. Med. 2008, 22, 849-858.
65. Kostarelos, K.; Emfietzoglou, D. Tissue dosimetry of liposomeradionuclide complexes for internal radiotherapy: toward liposometargeted therapeutic radiopharmaceuticals. Anticancer Res. 2000, 20, 3339-3345.
66. Chen, J.; Wu, H.; Han, D.; Xie, C. Using anti-VEGF McAb and magnetic nanoparticles as double-targeting vector for the radioimmunotherapy of liver cancer. Cancer Lett. 2006, 231, 169-175.
67. Park, Y. J.; Nah, S. H.; Lee, J. Y.; Jeong, J. M.; Chung, J. K.; Lee, M. C.; Yang, V. C.; Lee, S. J. Surface-modified poly(lactide-coglycolide) nanospheres for targeted bone imaging with enhanced labeling and delivery of radioisotope. J. Biomed. Mater. Res. A 2003, 67, 751-760.
68. Liu, Z.; Jin, C.; Yu, Z.; Zhang, J.; Liu, Y.; Zhao, H.; Jia, B.; Wang, F. Radioimmunotherapy of human colon cancer xenografts with 131I-labeled anti-CEA monoclonal antibody. Bioconjugate. Chem. 2010, 21, 314-318.
69. Zielhuis, S. W.; Seppenwoolde, J. H.; Mateus, V. A.; Bakker, C. J.; Krijger, G. C.; Storm, G.; Zonnenberg, B. A.; van het Schip, A. D.; Koning, G. A.; Nijsen, J. F. Lanthanide-loaded liposomes for multimodality imaging and therapy. Cancer Biother. Radiopharm. 2006, 21, 520-527.
70. Emfietzoglou, D.; Kostarelos, K.; Sgouros, G. An analytic dosimetry study for the use of radionuclide-liposome conjugates in internal radiotherapy. J. Nucl. Med. 2001, 42, 499-504.
71. Yuan, J.; You, Y.; Lu, X.; Muzik, O.; Oupicky D.; Peng, F. Synthesis and characterization of nano-sized Poly(APMA)-DOTACopper conjugate for radionuclide cancer therapy: Assessment of stability and distribution in vivo by microPET imaging. J. Nucl. Med. 2006, 47, 419P.
72. Khan, M. K.; Minc, L. D.; Nigavekar, S. S.; Kariapper, M. S.; Nair, B. M.; Schipper, M.; Cook, A. C.; Lesniak, W. G.; Balogh, L. P. Fabrication of {198Au0} radioactive composite nanodevices and their use for nanobrachytherapy. Nanomedicine 2008, 4, 57-69.
73. Chanda, N.; Kan, P.; Watkinson, L. D.; Shukla, R.; Zambre, A.; Carmack, T. L.; Engelbrecht, H.; Lever, J. R.; Katti, K.; Fent, G. M.; Casteel, S. W.; Smith, C. J.; Miller, W. H.; Jurisson, S.; Boote, E.; Robertson, J. D.; Cutler, C.; Dobrovolskaia, M.; Kannan, R.; Katti, K. V. Radioactive gold nanoparticles in cancer therapy: therapeutic efficacy studies of GA-198AuNP nanoconstruct in prostate tumor-bearing mice. Nanomedicine 2010, 6, 201-209.
74. Erdogan, S.; Roby, A.; Torchilin, V. P. Enhanced tumor visualization by γ-scintigraphy with 111In-labeled polychelatingpolymer-containing immunoliposomes. Mol. Pharm. 2006, 3, 525-530.
75. Liu, X.; Wang, Y.; Nakamura, K.; Kawauchi, S.; Akalin, A.; Cheng, D.; Chen, L.; Rusckowski, M.; Hnatowich, D. J. Auger radiation-induced, antisense-mediated cytotoxicity of tumor cells using a 3-component streptavidin-delivery nanoparticle with111In. J. Nucl. Med. 2009, 50, 582-590.
76. Chow, T. H.; Lin, Y. Y.; Hwang, J. J.; Wang, H. E.; Tseng, Y. L.; Pang, V. F.; Liu, R. S.; Lin, W. J.; Yang, C. S.; Ting, G. Therapeutic efficacy evaluation of 111In-labeled PEGylated liposomal vinorelbine in murine colon carcinoma with multimodalities of molecular imaging. J. Nucl. Med. 2009, 50, 2073-2081.
77. Tsotsalas, M. M.; Kopka, K.; Luppi, G.; Wagner, S.; Law, M. P.; Schäfers, M.; De Cola, L. Encapsulating 111In in nanocontainers for scintigraphic imaging: synthesis, characterization, and in vivo biodistribution. ACS Nano. 2010, 4, 342-348.
78. Nie, H.; He, A.; Jia, B.; Wang, F.; Jiang, Q.; Han, C. C. A novel carrier of radionuclide based on surface modified poly(lactide-coglycolide) nanofibrous membrane. Polymer 2010, 51, 3344-3348.
79. Dobrovolskaia, M. A.; McNeil, S. E. Immunological properties of engineered nanomaterials. Nature Nanotechnol. 2007, 2, 469-478.
80. Paszko, E.; Ehrhardt, C.; Senge, M. O.; Kelleher, D. P.; Reynolds, J. V. Nanodrug applications in photodynamic therapy. Photodiagn. Photodyn. 2011, 8, 14-29.
81. Chen, W.; Zhang J. Using nanoparticles to enable simultaneous radiation and photodynamic therapies for cancer treatment. J. Nanosci. Nanotechnol. 2006, 6, 1159-1166.
82. Chen, Z. L.; Sun, Y.; Huang, P.; Yang, X. X.; Zhou, X. P. Studies on preparation of photosensitizer loaded magnetic silica nanoparticles and their anti-tumor effects for targeting photodynamic therapy. Nanoscale. Res. Lett. 2009, 4, 400-408.
83. Calzavara-Pinton, P. G.; Venturini, M.; Sala, R. Photodynamic therapy: update 2006. Part 1: photochemistry and photobiology. J. Eur. Acad. Dermatol. Venereol. 2007, 21, 293-302.
84. Sibani, S. A.; McCarron, P. A.; Woolfson, A. D.; Donnelly, R. F. Photosensitiser delivery for photodynamic therapy. Part 1: systemic carrier platforms. Expert Opin. Drug Deliv. 2008, 5, 1241-1254.
85. Chouikrat, R.; Seve, A.; Vanderesse, R.; Benachour, H.; Barberi-Heyob, M.; Richeter, S.; Raehm, L.; Durand, J. O.; Verelst, M.; Frochot, C. Non polymeric nanoparticles for photodynamic therapy applications: recent developments. Curr. Med. Chem. 2012, 19, 781-792.
86. Sinha, R.; Kim, G. J.; Nie, S.; Shin, D. M. Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery. Mol. Cancer Ther. 2006, 5, 1909-1917.
87. Allen, T. M.; Cullis, P. R. Drug delivery systems: entering the mainstream. Science 2004, 303, 1818-1822.
88. Edens, H. A.; Levi, B. P.; Jaye, D. L.; Walsh, S.; Reaves, T. A.; Turner. J. R.; Nusrat, A.; Parkos, C. A. Neutrophil transepithelial migration: evidence for sequential, contact-dependent signaling events and enhanced paracellular permeability independent of transjunctional migration. J. Immunol. 2002, 169, 476-486.
89. Derycke, A. S.; de Witte, P. A. Liposomes for photodynamic therapy. Adv. Drug Deliv. Rev. 2004, 56, 17-30.
90. Li, B.; Moriyama, E. H.; Li, F.; Jarvi, M. T.; Allen, C.; Wilson, B. C. Diblock copolymer micelles deliver hydrophobic protoporphyrin IX for photodynamic therapy. Photochem. Photobiol. 2007, 83, 1505-1512.
91. van Nostrum, C. F. Polymeric micelles to deliver photosensitizers for photodynamic therapy. Adv. Drug. Deliv. Rev. 2004, 56, 9-16.
92. Zhang, G. D.; Harada, A.; Nishiyama, N.; Jiang, D. L.; Koyama, H.; Aida, T.; Kataoka, K. Polyion complex micelles entrapping cationic dendrimer porphyrin: effective photosensitizer for photodynamic therapy of cancer. J. Control. Release 2003, 93, 141-150.
93. Nishiyama, N.; Morimoto, Y.; Jang, W. D.; Kataoka, K. Design and development of dendrimer photosensitizer-incorporated polymeric micelles for enhanced photodynamic therapy. Adv. Drug. Deliv. Rev. 2009, 61, 327-338.
94. Ricci-Júnior, E.; Marchetti, J. M. Preparation, characterization, photocytotoxicity assay of PLGA nanoparticles containing zinc (II) phthalocyanine for photodynamic therapy use. J. Microencapsul 2006, 23, 523-538.
95. Yoon, H. Y.; Koo, H; Choi, K. Y.; Lee, S. J.; Kim, K; Kwon, I. C.; Leary, J. F.; Park, K.; Yuk, S. H.; Park, J. H.; Choi, K. Tumortargeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. Biomaterials 2012, 33, 3980-3989.
96. Tsay, J. M.; Trzoss, M.; Shi, L.; Kong, X.; Selke, M.; Jung, M. E.; Weiss, S. Singlet oxygen production by peptide-coated quantum dot-photosensitizer conjugates. J. Am. Chem. Soc. 2007, 129, 6865-6871.
97. Yaghini, E.; Seifalian, A. M.; MacRobert, A. J. Qantum dots and their potential biomedical applications in photosensitization for photodynamic therapy. Nanomedicine (Lond.) 2009, 4, 353-363.
98. Samia, A. C.; Chen, X.; Burda, C. Semiconductors quantum dots for photodynamic therapy. J. Am. Chem. Soc. 2003, 125, 15736-15737.
99. Juzenas, P.; Chen, W.; Sun, Y. P.; Coelho, M. A.; Generalov, R.; Generalova, N.; Christensen, I. L. Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer. Adv. Drug. Deliv. Rev. 2008, 60, 1600-1614.
100. Zhao, B.; Yin, J. J.; Bilski, P. J.; Chignell, C. F.; Roberts, J. E.; He, Y. Y. Enhanced photodynamic efficacy towards melanoma cells by encapsulation of Pc4 in silica nanoparticles. Toxicol. Appl. Pharmacol. 2009, 241, 163-172.
101. Chang, M. Y.; Shiau, A. L.; Chen, Y. H.; Chang, C. J.; Chen, H. H.; Wu, C. L. Increased apoptotic potential and dose-enhancing effect of gold nanoparticles in combination with single-dose clinical electron beams on tumor-bearing mice. Cancer Sci. 2008, 99, 1479-1484.
102. Hainfeld, J. F.; Slatkin, D. N.; Smilowitz, H. M. The use of gold nanoparticles to enhance radiotherapy in mice. Phys. Med. Biol. 2004, 49, N309-N315.
103. Kong, T.; Zeng, J.; Wang, X.; Yang, X.; Yang, J.; McQuarrie, S.; McEwan, A.; Roa, W.; Chen, J.; Xing, J. Z. Enhancement of radiation cytotoxicity in breast-cancer cells by localized attachment of gold nanoparticles. Small 2008, 4, 1537-1543.
104. Hainfeld, J. F.; Dilmanian, F. A.; Slatkin, D. N.; Smilowitz, H. M. Radiotherapy enhancement with gold nanoparticles. J. Pharm. Pharmacol. 2008, 60, 977-985.
105. Foley, E. A.; Carter, J. D.; Shan, F.; Guo, T. Enhanced relaxation of nanoparticle-bound supercoiled DNA in X-ray radiation. Chem. Commun. 2005, 3192-3194.
106. Zheng, Y.; Hunting, D. J.; Ayotte, P.; Sanche, L. Radiosensitization of DNA by gold nanoparticles irradiated with high-energy electrons. Radiat. Res. 2008, 169, 19-27.
107. Jain, S.; Butterworth, K.; Prise, K. M.; O'Sullivan, J. M.; Hirst, D. G. Gold nanoparticles cause radiosensitization in prostate cancer cell lines in hypoxic conditions. Int. J. Radiat. Oncol. Biol. Phys. 2008, 72, S715-S716.
108. Kobayashi, K.; Usami, N.; Porcel, E.; Lacombe, S.; Le Sech, C. Enhancement of radiation effect by heavy elements. Mutat. Res. 2010, 704, 123-131.
109. Zhang, S. X.; Gao, J.; Buchholz, T. A.; Wang, Z.; Salehpour, M. R.; Drezek, R. A.; Yu, T. K. Quantifying tumor-selective radiation dose enhancements using gold nanoparticles: a monte carlo simulation study. Biomed. Microdevices 2009, 11, 925-933.
110. Carter, J. D.; Cheng, N. N.; Qu, Y.; Suarez, G. D.; Guo, T. Nanoscale energy deposition by X-ray absorbing nanostructures. J. Phys. Chem. B 2007, 111, 11622-11625.
111. Ricci-Júnior, E.; Marchetti, J. M. Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use. Int. J. Pharm. 2006, 310,187-195.
112. Gomes, A. J.; Lunardi, C. N.; Tedesco, A. C. Characterization of biodegradable poly(D, L-lactide-co-glycolide) nanoparticles loaded with bacteriochlorophyll-a for photodynamic therapy. Photomed. Laser Surg. 2007, 25, 428-435.
113. Gomes, A. J.; Lunardi, L. O.; Marchetti, J. M.; Lunardi, C. N.; Tedesco, A. C. Photobiological and ultrastructural studies of nanoparticles of poly(lactic-co-glycolic acid)-containing bacteriochlorophyll-a as a photosensitizer useful for PDT treatment. Drug Deliv. 2005, 12, 159-164.
114. Yun, S. I.; Gadd, G. E.; Latella, B. A.; Lo, V.; Russell, R. A.; Holden P. J. Mechanical properties of biodegradable polyhydroxyalkanoates/single wall carbon nanotube nanocomposite films. Polym. Bull. 2008, 61, 267-275.
115. Zhu, Z.; Tang, Z.; Phillips, J. A.; Yang, R.; Wang, H.; Tan, W. Regulation of singlet oxygen generation using single-walled carbon nanotubes. J. Am. Chem. Soc. 2008, 130, 10857-10858.
116. Erbas, S.; Gorgulu, A.; Kocakusakogullari, M.; Akkaya, E. U. Noncovalent functionalized SWNTs as delivery agents for novel Bodipy-based potential PDT sensitizers. Chem. Commun. (Camb.) 2009, 4956-4958.
117. Kam, N. W. S.; O'Connell, M.; Wisdom, J. A.; Dai, H. Carbon nanotubes as multifunctional biological transporters and nearinfrared agents for selective cancer cell destruction. Proc. Natl. Acad. Sci. USA 2005, 102, 11600-11605.
118. Wang, M.; Abbineni, G.; Clevenger, A.; Mao, C.; Xu, S. Upconversion nanoparticles: synthesis, surface modification and biological applications. Nanomed. Nanotechnol. Biol. Med. 2011, 7, 710-29.
119. Wang, C.; Tao, H.; Cheng, L.; Liu, Z. Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials 2011, 32, 6145-6154.
120. Chin, W. W.; Heng, P. W.; Thong, P. S.; Bhuvaneswari, R.; Hirt, W.; Kuenzel, S.; Soo, K. C.; Olivo, M. Improved formulation of photosensitizer chlorin e6 polyvinylpyrrolidone for fluorescence diagnostic imaging and photodynamic therapy of human cancer. Eur. J. Pharm. Biopharm. 2008, 69, 1083-1093.
121. Yamamoto, T.; Nakai, K.; Kageji, T.; Kumada, H.; Endo, K.; Matsuda, M.; Shibata, Y.; Matsumura, A. Boron neutron capture therapy for newly diagnosed glioblastoma. Radiother. Oncol. 2009, 91, 80-84.
122. Sharma, P.; Brown, S. C.; Walter, G.; Santra, S.; Scott, E.; Ichikawa, H.; Fukumori, Y.; Moudgil, B. M. Gd nanoparticulates: from magnetic resonance imaging to neutron capture therapy. Adv. Powder Technol. 2007, 18, 663-698.
123. Fukumori, Y.; Ichikawa, H. Nanoparticles for cancer therapy and diagnosis. Adv. Powder Technol. 2006, 17, 1-28.
124. Pan, X.; Wu, G.; Yang, W.; Barth, R. F.; Tjarks, W.; Lee, R. J. Synthesis of cetuximab-immunoliposomes via a cholesterol-based membrane anchor for targed delivery of a neutron capture therapy (NCT) agent to glioma cells. Bioconjug. Chem. 2007, 18, 101-108.
125. Miyamoto, M.; Ichikawa, H.; Fukumori, Y.; Akine, Y.; Tokuuye, K. Design and preparation of gadolinium-reservoir microcapsules for neutron-capture therapy by means of the Wurster process. Chem. Pharm. Bull. (Tokyo) 1997, 45, 2043-2050.
126. Pickering, A. L.; Mitterbauer, C.; Browing, N. D.; Kauzlarich, S. M.; Power, P. P. Room temperature synthesis of surfacefunctionalised boron nanoparticles. Chem. Commun. 2007, 6, 580-582.
127. Golberg, D.; Bando, Y.; Tang, C. C,; Zhi, C. Y. Boron Nitride Nanotubes. Adv. Mater. 2007, 19, 2413-2432.
128. Zhi, C.; Bando, Y.; Tang, C.; Golberg, D. Boron nitride nanotubes. Mater. Sci. Eng. R 2010, 70, 92-111.
129. Menichetti, L.; De Marchi, D.; Calucci, L.; Ciofani, G.; Menciassi, A.; Forte, C. Boron nitride nanotubes for boron neutron capture therapy as contrast agents in magnetic resonance imaging at 3 T. Appl. Radiat. Isot. 2011, 69, 1725-1727.
130. Le U. M.; Cui, Z. Biodistribution and tumor-accumulation of gadolinium (Gd) encapsulated in long-circulating liposomes in tumor-bearing mice for potential neutron capture therapy. Int. J. Pharm. 2006, 320, 96-103.
131. Le, U. M.; Cui, Z. Long-circulating gadolinium-encapsulated liposomes for potential application in tumor neutron capture therapy. Int. J. Pharm. 2006, 312, 105-112.
132. Kobayashi, H.; Kawamoto, S.; Saga, T.; Sato, N.; Ishimori, T.; Konishi, J.; Ono, K.; Togashi, K.; Brechbiel, M. W. Avidin-dendrimer-(1B4M-Gd)(254): a tumor-targeting therapeutic agent for gadolinium neutron capture therapy of intraperitoneal disseminated tumor which can be monitored by MRI. Bioconjug. Chem. 2001, 12, 587-593.
133. Watanabe, T.; Ichikawa, H.; Fukumori, Y. Tumor accumulation of gadolinium in lipidnanoparticles intravenously injected for neutroncapture therapy of cancer. Eur. J. Pharm. Biopharm. 2002, 54, 119-124.
134. Miyamoto, M.; Hirano, K.; Ichikawa, H.; Fukumori, Y.; Akine, Y.; Tokuuye, K. Biodistribution of gadolinium incorporated in lipid emulsions intraperitoneally administered for neutroncapture therapy with tumor-bearing hamsters. Biol. Pharm. Bull. 1999, 22, 1331-1340.
135. Miyamoto, M.; Hirano, K.; Ichikawa, H.; Fukumori, Y.; Akine Y.; Tokuuye, K. Preparation of gadolinium-containing emulsions stabilized with phosphatidylcholine-surfactant mixtures for neutron-capture therapy. Chem. Pharm. Bull. 1999, 47, 203-208.
136. Mehnert, W.; Mäder, K. Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. 2001, 47, 165-196.
137. Muller, R. H.; Mehnert, W.; Lucks, J. S.; Schwarz, C.; zur Muhlen, A.; Meyhers, H.; Freitas, C.; Ruhl, D. Solid lipid nanoparticles (SLN): an alternative colloidal carrier system for controlled drug delivery. Eur. J. Pharm. Biopharm. 1995, 41, 62-69.
138. Schwarz, C.; Mehnert, W. Solid lipid nanoparticles (SLN) for controlled drug delivery. II. Drug incorporation and physicochemical characterization. J. Microencapsul. 1999, 16, 205-213.
139. zur Muhlen, A.; Schwarz, C.; Mehnert, W. Solid lipid nanoparticles (SLN) for controlled drug delivery-drug release and release mechanism. Eur. J. Pharm. Biopharm. 1998, 45, 149-155.
140. Oyewumi, M. O.; Mumper, R. J. Gadolinium-loaded nanoparticles engineered from microemulsion templates. Drug Dev. Ind. Pharm. 2002, 28, 317-328.
141. Kean, T.; Roth. S.; Thanou, M. Trimethylated chitosans as nonviral gene delivery vectors: cytotoxicity and transfection efficiency. J. Control. Release 2005, 103, 643-653.
142. Saha, T. K.; Ichikawa, H.; Fukumori, Y. Gadolinium diethylenetriaminopentaacetic acid-loaded chitosan microspheres for gadolinium neutron-capture therapy. Carbohydr. Res. 2006, 341, 2835-2841.
143. Tokumitsu, H.; Ichikawa, H.; Fukumori, Y. Chitosan-gadopentetic acid complex nanoparticles for gadolinium neutron-capture therapy of cancer: preparation by novel emulsion-droplet coalescence technique and characterization. Pharm. Res. 1999, 16, 1830-1835.
144. Akamatsu, K. Development of a thermal neutron-sensitive liposome for a novel drug delivery system aiming for radio-chemoconcurrent cancer therapy. Radiat. Phys. Chem. 2009, 78, 1179-1183.
145. Yanagie, H.; Maruyama, K.; Takizawa, T.; Ishida, O.; Ogura, K.; Matsumoto, T.; Sakurai, Y.; Kobayashi, T.; Shinohara, A.; Rant, J.; Skvarc, J.; Ilic, R.; Kuhne, G.; Chiba, M.; Furuya, Y.; Sugiyama, H.; Hisa, T.; Ono, K.; Kobayashi, H.; Eriguchi. M. Application of boron-entrapped stealth liposomes to inhibition of growth of tumour cells in the in vivo boron neutron-capture therapy model. Biomed. Pharmacother. 2006, 60, 43-50.
146. Adams, G. P.; Schier, R.; McCall, A. M.; Simmons, H. H.; Horak, E. M.; Alpaugh, R. K.; Marks, J. D.; Weiner, L. M. High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. Cancer Res. 2001, 61, 4750-4755.
147. Yang, W.; Barth, R. F.; Wu, G.; Bandyopadhyaya, A. K.; Thirumamagal, B. T.; Tjarks, W.; Binns, P. J.; Riley, K.; Patel, H.; Coderre, J. A.; Ciesielski, M. J.; Fenstermaker, R. A. Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas. Appl. Radiat. Isot. 2004, 61, 981-985.
148. Porras, I. Sulfur-33 nanoparticles: A Monte Carlo study of their potential as neutron capturers for enhancing boron neutron capture therapy of cancer. Appl. Radiat. Isot. 2011, 69, 1838-1841.
149. Huang, X.; Jain, P. K.; El-Sayed, I. H.; El-Sayed, M. A. Plasmonic photothermal therapy (PPTT) using gold nanoparticles. Lasers Med. Sci. 2008, 23, 217-228.
150. Maksimova, I. L.; Akchurin, G. G.; Khlebtsov, B. N.; Terentyuk, G. S.; Akchurin, G. G.; Ermolaeva, I. A.; Skaptsov, A. A.; Soboleva, E. P.; Khlebtsov N. G.; Tuchin, V. V. Near-infrared laser photothermal therapy of cancer by using gold nanoparticles: Computer simulations and experiment. Medic. Laser App. 2007, 22, 199-206.
151. Paciotti, G. F.; Myer, L.; Weinreich, D.; Goia, D.; Pavel, N.; McLaughlin, R. E.; Tamarkin, L. Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery. Drug Deliv. 2004, 11, 169-183.
152. Huang, X.; El-Sayed, M. A. Gold nanoparticles: Optical properties and implementations in cancer diagnosis and photothermal therapy. J. Adv. Res. 2010, 1, 13-28.
153. Li, J. L.; Wang, L.; Liu, X. Y.; Zhang, Z. P.; Guo, H. C.; Liu, W. M.; Tang, S. H. In vitro cancer cell imaging and therapy using transferrin-conjugated gold nanoparticles. Cancer Lett. 2009, 274, 319-326.
154. Kalele, S.; Gosavi, S. W.; Urban, J.; Kulkarni, S. K. Nanoshell particles: synthesis, properties and applications. Curr. Sci. 2006, 91, 1038-1052.
155. Kim, P. S.; Djazayeri, S.; Zeineldin, R. Novel nanotechnology approaches to diagnosis and therapy of ovarian cancer. Gynecol. Oncol. 2011, 120, 393-403.
156. Longmire, M.; Choyke, P. L.; Kobayashi, H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond.) 2008, 3, 703-717.
157. Chen, A. M.; Zhang, M.; Wei, D.; Stueber, D.; Taratula, O.; Minko, T.; He, H. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy inmultidrug-resistant cancer cells. Small 2009, 5, 2673-2677.
158. Vokes, E. E.; Weichselbaum, R. R. Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J. Clin. Oncol. 1990, 8, 911-934.
159. Seiwert, T. Y.; Salama, J. K.; Vokes, E. E. The concurrent chemoradiation paradigm-general principles. Nat. Clin. Pract. Oncol. 2007, 4, 86-100.
160. Maduro, J. H.; Pras, E.; Willemse, P. H.; de Vries, E. G. Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer. Cancer Treat. Rev. 2003, 29, 471-488.
161. O'Rourke, N.; Roqué I Figuls, M.; Farré Bernadó, N.; Macbeth, F. Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst. Rev. 2010, 16, CD002140.
162. Fuks, Z.; Leibel, S. A.; Kutcher, G. J.; Mohan, R.; Ling, C. C. Three-dimensional conformal treatment: a new frontier in radiation therapy. Important Adv. Oncol. 1991, 151-172.
163. Bernier, J.; Hall, E. J.; Giaccia, A. Radiation oncology: a century of achievements. Nat. Rev. Cancer 2004, 4, 737-747.
164. Duncan, R. Polymer conjugates as anticancer nanomedicines. Nat. Rev. Cancer 2006, 6, 688-701.
165. Moses, M. A.; Brem, H.; Langer, R. Advancing the field of drug delivery: taking aim at cancer. Cancer Cell 2003, 4, 337-341.
166. Lammers, T.; Subr, V.; Peschke, P.; Kühnlein, R.; Hennink, W. E.; Ulbrich, K.; Kiessling, F.; Heilmann, M.; Debus, J.; Huber P. E.; Storm, G. Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy. Br. J. Cancer 2008, 99, 900-910.
167. Morton, J. G.; Day, E. S.; Halas, N. J.; West, J. L. Nanoshells for photothermal cancer therapy. Methods Mol. Biol. 2010, 624, 101-117.
168. Müller, S. Magnetic fluid hyperthermia therapy for malignant brain tumors-an ethical discussion. Nanomedicine 2009, 5, 387-393.
169. Jordan, A.; Maier-Hauff, K. Magnetic nanoparticles for intracranial thermotherapy. J. Nanosci. Nanotechnol. 2007, 7, 4604-4606.
170. Jordan, A.; Scholz, R.; Wust, P.; Fähling, H.; Felix, R. Magnetic fluid hyperthermia (MFH): cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles. J. Magn. Magn. Mater. 1999, 201, 413-419.
171. Gourevich, D.; Gerold, B.; Arditti, F.; Xu, D.; Liu, D.; Volovick, A.; Wang, L.; Medan, Y.; Gnaim, J.; Prentice, P.; Cochran, S.; Melzer, A. v drug delivery and tumour cell. Adv. Exp. Med. Biol. 2012, 733, 135-144.
172. Raoof, M.; Curley, S. A. Non-invasive radiofrequency-induced targeted hyperthermia for the treatment of hepatocellular carcinoma. Int. J. Hepatol. 2011, 2011, 1-6.
173. Meenach, S. A.; Hilt, J. Z.; Anderson, K. W. Poly(ethylene glycol)-based magnetic hydrogel nanocomposites for hyperthermia cancer therapy. Acta Biomater. 2010, 6, 1039-1046.
174. Falk, M. H.; Issels, R. D. Hyperthermia in oncology. Int. J. Hyperthermia. 2001, 17, 1-18.
175. Issels, R. D. Hyperthermia adds to chemotherapy. Eur. J. Cancer 2008, 44, 2546-2554.
176. Moroz, P.; Jones, S. K.; Gray, B. N. Magnetically mediated hyperthermia: current status and future directions. Int. J. Hyperthermia. 2002, 18, 267-284.
177. Nikfarjam, M.; Muralidharan, V.; Christophi, C. Mechanisms of focal heat destruction of liver tumors. J. Surg. Res. 2005, 127, 208-223.
178. Burke, A.; Ding, X.; Singh, R.; Kraft, R. A.; Levi-Polyachenko, N.; Rylander, M. N.; Szot, C.; Buchanan, C.; Whitney, J.; Fisher, J.; Hatcher, H. C.; D'Agostino, R. Jr.; Kock, N. D.; Ajayan, P. M.; Carroll, D. L.; Akman, S.; Torti, F. M.; Torti, S. V. Long-term survival following a single treatment of kidney tumors with multiwalled carbon nanotubes and near-infrared radiation. Proc. Natl. Acad. Sci. USA 2009, 106, 12897-12902.
179. Guedes, M. H. A.; Sadeghiana, N.; Peixoto, D. L. G.; Coelho, J. P.; Barbosa, L. S.; Azevedo, R. B.; Kückelhaus, S.; Da Silva, M. F.; Morais, P. C.; Lacava, Z. G. M. Effects of AC magnetic field and carboxymethyldextran-coated magnetite nanoparticles on mice peritoneal cells. J. Magn. Magn. Mater. 2005, 293, 283-286.
180. Cherukuri, P.; Glazer, E. S.; Curley, S. A. Targeted hyperthermia using metal nanoparticles. Adv. Drug. Deliv. Rev. 2010, 62, 339-345.
181. Hirsch, L. R.; Gobin, A. M.; Lowery, A. R.; Tam, F.; Drezek, R. A.; Halas, N. J.; West, J. L. Metal nanoshells. Ann. Biomed. Eng. 2006, 34, 15-22.
182. Su, Y.; Wei, X.; Peng, F.; Zhong, Y.; Lu, Y.; Su, S.; Xu, T.; Lee, S. T.; He, Y. Gold nanoparticles-decorated silicon nanowires as highly efficient near-infrared hyperthermia agents for cancer cells destruction. Nano. Lett. 2012, 12, 1845-1850.
183. Hao, E.; Bailey, R. C.; Schatz, G. C.; Hupp, J. T.; Li, S. Synthesis and optical properties of "Branched" gold nanocrystals. Nano Lett. 2004, 4, 327-330.
184. Nehl, C. L.; Liao, H.; Hafner, J. H. Optical Properties of Star-Shaped Gold Nanoparticles. Nano Lett. 2006, 6, 683-688.
185. Van de Broek, B.; Devoogdt, N.; D'Hollander, A.; Gijs, H. L.; Jans, K.; Lagae, L.; Muyldermans, S.; Maes, G.; Borghs G. Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy. ACS Nano 2011, 5, 4319-4328.
186. Jin, H.; Yang, P.; Cai, J.; Wang, J.; Liu, M. Photothermal effects of folate-conjugated gold nanorods on HepG2 cells. Appl. Microbiol. Biotechnol. 2012, DOI: 10.1007/s00253-012-3935-1.
187. Link, S.; El-Sayed, M. A. Spectral properties and relaxation dynamics of surface plasmon electronic oscillations in gold and silver nanodots and nanorods. J. Phys. Chem. B 1999, 103, 8410-8426.
188. Link, S.; El-Sayed, M. A. Shape and size dependence of radiative, non-radiative and photothermal properties of gold nanocrystals. Int. Rev. Phys. Chem. 2000, 19, 409-453.
189. Link, S.; El-Sayed, M. A. Optical properties and ultrafast dynamics of metallic nanocrystals. Annu. Rev. Phys. Chem. 2003, 54, 331-366.
190. Kubik, T.; Bogunia-Kubik, K.; Sugisaka, M. Nanotechnology on duty in medical applications. Curr. Pharm. Biotechnol. 2005, 22, 17-33.
191. Xu, Y.; Mahmood, M.; Fejleh, A.; Li, Z.; Watanabe, F.; Trigwell, S.; Little, R. B.; Kunets, V. P.; Dervishi, E.; Biris, A. R.; Salamo, G. J.; Biris, A. S. Carbon-covered magnetic nanomaterials and their application for the thermolysis of cancer cells. Int. J. Nanomedicine 2010, 7, 167-176.
192. Zharov, V. P.; Galitovskaya, E. N.; Johnson, C.; Kelly, T. Synergistic enhancement of selective nanophotothermolysis with gold nanoclusters: potential for cancer therapy. Lasers Surg. Med. 2005, 37, 219-226.
193. Iancu, C.; Mocan, L. Advances in cancer therapy through the use of carbon nanotube-mediated targeted hyperthermia. Int. J. Nanomedicine. 2011, 6, 1675-1684.
194. Torti, S. V.; Byrne, F.; Whelan, O.; Levi, N.; Ucer, B.; Schmid, M.; Torti, F. M.; Akman, S.; Liu, J.; Ajayan, P. M.; Nalamasu, O.; Carroll, D. L. Thermal ablation therapeutics based on CN(x) multiwalled nanotubes. Int. J. Nanomedicine 2007, 2, 707-714.
195. Ghosh, S.; Dutta, S.; Gomes, E.; Carroll, D.; D'Agostino, R. Jr.; Olson, J.; Guthold, M.; Gmeiner, W. H. Increased heating efficiency and selective thermal ablation of malignant tissue with DNA-encased multiwalled carbon nanotubes. ACS Nano 2009, 3, 2667-2673.
196. Huang, X.; El-Sayed, I. H.; Qian, W.; El-Sayed, M. A. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J. Am. Chem. Soc. 2006, 128, 2115-2120.
197. Zhu, T. C.; Finlay, J. C.; Hahn, S. M.; Determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic therapy. J. Photochem. Photobiol. B 2005, 79, 231-241.
198. Krishnan, S.; Diagaradjane, P.; Cho, S. H. Nanoparticle-mediated thermal therapy: evolving strategies for prostate cancer therapy. Int. J. Hyperthermia. 2010, 26, 775-789.
199. Curley, S. A.; Marra, P.; Beaty, K.; Ellis, L. M.; Vauthey, J. N.; Abdalla, E. K.; Scaife, C.; Raut, C.; Wolff, R.; Choi, H.; Loyer, E.; Vallone, P.; Fiore, F.; Scordino, F.; De Rosa, V.; Orlando, R.; Pignata, S.; Daniele, B.; Izzo, F. Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann. Surg. 2004, 239, 450-458.
200. Haemmerich, D.; Laeseke, P. F. Thermal tumour ablation: devices, clinical applications and future directions. Int. J. Hyperthermia 2005, 21, 755-760.
201. Imamura, J.; Tateishi, R.; Shiina, S.; Goto, E.; Sato, T.; Ohki, T.; Masuzaki, R.; Goto, T.; Yoshida, H.; Kanai, F.; Hamamura, K.; Obi, S.; Yoshida, H.; Omata, M. Neoplastic seeding after radiofrequency ablation for hepatocellular carcinoma. Am. J. Gastroenterol. 2008, 103, 3057-3062.
202. Glazer, E. S.; Curley, S. A. Radiofrequency field-induced thermal cytotoxicity in cancer cells treated with fluorescent nanoparticles. Cancer, 2010, 116, 3285-3293.
203. Curley, S. A.; Cherukuri, P.; Briggs, K.; Patra C. R.; Upton, M.; Dolson, E.; Mukherjee, P. Noninvasive radiofrequency fieldinduced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles. J. Exp. Ther. Oncol. 2008, 7, 313-326.
204. Glazer, E. S.; Massey, K. L.; Zhu, C.; Curley, S. A. Pancreatic carcinoma cells are susceptible to noninvasive radio frequency fields after treatment with targeted gold nanoparticles. Surgery 2010, 148, 319-324.
205. Cherukuri, P.; Curley, S. A. Use of nanoparticles for targeted, noninvasive thermal destruction of malignant cells. Methods Mol. Biol. 2010, 624, 359-373.
206. Gannon, C. J.; Cherukuri, P.; Yakobson, B. I.; Cognet, L.; Kanzius, J. S.; Kittrell, C.; Weisman, R. B.; Pasquali, M.; Schmidt, H. K.; Smalley R. E.; Curley, S. A. Carbon nanotube-enhanced thermal destruction of cancer cells in a noninvasive radiofrequency field. Cancer. 2007, 110, 12, 2654-2665.
207. Wang, X.; Wang, C.; Cheng, L.; Lee, S. T.; Liu, Z. Noble Metal Coated Single-Walled Carbon Nanotubes for Applications in Surface Enhanced Raman Scattering Imaging and Photothermal Therapy. J. Am. Chem. Soc. 2012, DOI: 10.1021/ja300140c.
208. Hergt, R.; Hiergeist, R.; Hilger, I.; Kaiser, W. A.; Lapatnikov, Y.; Margel, S.; Richter, U. Maghemite nanoparticles with very high AC-losses for application in RF-magnetic hyperthermia. J. Magn. Magn. Mater. 2004, 270, 345-357.
209. Gannon, C. J.; Patra, C. R.; Bhattacharya, R.; Mukherjee, P.; Curley, S. A. Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells. J. Nanobiotechnology 2008, 6, 2.
210. Raoof, M.; Corr, S. J.; Kaluarachchi, W. D.; Massey, K. L.; Briggs, K.; Zhu, C.; Cheney, M. A.; Wilson, L. J.; Curley, S. A. Stability of antibody-conjugated gold nanoparticles in the endolysosomal nanoenvironment: implications for noninvasive radiofrequencybased cancer therapy. Nanomedicine 2012, DOI: 10.1016/j.nano. 2012.02.001.
211. Rastogi, R.; Gulati, N.; Kotnala, R. K.; Sharma, U.; Jayasundar, R.; Koul, V. Evaluation of folate conjugated pegylated thermosensitive magnetic nanocomposites for tumor imaging and therapy. Colloids Surf. B Biointerfaces 2011, 82, 160-167.
212. Wada, S.; Yue, L.; Tazawa, K.; Furuta, I.; Nagae, H.; Takemori, S. Minamimura T. New local hyperthermia using dextran magnetite complex (DM) for oral cavity: experimental study in normal hamster tongue. Oral Dis. 2001, 7, 192-195.
213. Jordan A, Scholz R, Maier-Hauff K, van Landeghem, F. K.; Waldoefner, N.; Teichgraeber, U.; Pinkernelle, J.; Bruhn, H.; Neumann, F.; Thiesen, B.; von Deimling, A.; Felix, R. The effect of thermotherapy using magnetic nanoparticles on rat malignant glioma. J. Neurooncol. 2006, 78, 7-14.
214. Kawai, N.; Futakuchi, M.; Yoshida, T.; Ito, A.; Sato, S.; Naiki, T.; Honda, H.; Shirai, T.; Kohri, K. Effect of heat therapy using magnetic nanoparticles conjugated with cationic liposomes on prostate tumor in bone. Prostate 2008, 68, 784-792.
215. Hilger, I.; Hiergeist, R.; Hergt, R.; Winnefeld, K.; Schubert, H.; Kaiser, W. A. Thermal ablation of tumors using magnetic nanoparticles: an in vivo feasibility study. Invest. Radiol. 2002, 37, 580-586.
216. Wust, P.; Gneveckow, U.; Johannsen, M.; Böhmer, D.; Henkel, T.; Kahmann, F.; Sehouli, J.; Felix, R.; Ricke, J.; Jordan, A. Magnetic nanoparticles for interstitial thermotherapy-feasibility, tolerance and achieved temperatures. Int. J. Hyperthermia 2006, 22, 673-685.
217. Maier-Hauff, K.; Rothe, R.; Scholz, R.; Gneveckow, U.; Wust, P.; Thiesen, B.; Feussner, A.; von Deimling, A.; Waldoefner, N.; Felix, R.; Jordan, A. Intracranial thermotherapy using magnetic nanoparticles combined with external beam radiotherapy: results of a feasibility study on patients with glioblastoma multiforme. J. Neurooncol 2007, 81, 53-60.
218. Johannsen, M.; Gneveckow, U.; Eckelt, L.; Feussner, A.; Waldöfner, N.; Scholz, R.; Deger, S.; Wust, P.; Loening, S. A.; Jordan, A. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique. Int. J. Hyperthermia 2005, 21, 637-647.
219. Thiesen, B.; Jordan, A. Clinical applications of magnetic nanoparticles for hyperthermia. Int. J. Hyperthermia 2008, 24, 467-474.
220. Rodríguez-Luccioni, H. L.; Latorre-Esteves, M.; Méndez-Vega, J.; Soto, O.; Rodríguez, A. R.; Rinaldi, C.; Torres-Lugo, M. Enhanced reduction in cell viability by hyperthermia induced by magnetic nanoparticles. Int. J. Nanomedicine 2011, 6, 373-380.
221. Silva, A. C.; Oliveira, T. R.; Mamani, J. B.; Malheiros, S. M.; Malavolta, L.; Pavon, L. F.; Sibov, T. T.; Amaro, E. Jr.; Tannús, A.; Vidoto, E. L.; Martins, M. J.; Santos, R. S.; Gamarra, L. F. Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment. Int. J. Nanomedicine 2011, 6, 591-603.
222. Wang, D. S.; Li, J. G.; Li, H. P.; Tang, F. Q. Preparation and drug releasing property of magnetic chitosan-5-fluorouracil nanoparticles. T. Nonfer. Met. Soc. China 2009, 19, 1232-1236.
223. Ito, A.; Honda, H.; Kobayashi, T. Cancer immunotherapy based on intracellular hyperthermia using magnetite nanoparticles: a novel concept of "heatcontrolled necrosis" with heat shock protein expression. Cancer Immunol. Immunother. 2006, 55, 320-328.
224. Zhu, L.; Ma, J.; Jia, N.; Zhao, Y.; Shen, H. Chitosan-coated magnetic nanoparticles as carriers of 5-fluorouracil: preparation, characterization and cytotoxicity studies. Colloids Surf. B Biointerfaces 2009, 68, 1-6.
225. Cregg, P. J.; Murphy, K.; Mardinoglu, A. Calculation of nanoparticle capture efficiency in magnetic drug targeting. J. Magn. Magn. Mater. 2008, 320, 3272-3275.
226. Lin, J. J.; Chen, J. S.; Huang, S. J.; Ko, J. H.; Wang, Y. M.; Chen, T. L.; Wang, L. F. Folic acid-pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications. Biomaterials 2009, 30, 5114-5124.
227. Liangruksa, M.; Ganguly, R.; Puri, I. K. Parametric investigation of heating due to magnetic fluid hyperthermia in a tumor with blood perfusion. J. Magn. Magn. Mater. 2011, 323, 708-716.
228. Habib, A. H.; Ondeck, C. L.; Chaudhary, P.; Bockstaller, M. R.; McHenry, M. E. Evaluation of iron-cobalt/ferrite core-shell nanoparticles for cancer thermotherapy. J. App. Phys. 2008, 103, 07A307-07A307-3.
229. Mornet, S.; Vasseur, S.; Grasset, F.; Duguet, E. Magnetic nanoparticle design for medical diagnosis and therapy. J. Mat. Chem. 2004, 14, 2161-2175.
230. Pankhurst, Q. A.; Connolly, J.; Jones, S. K.; Dobson, J. Applications of magnetic nanoparticles in biomedicine. J. Phys. D App. Phys. 2003, 36, R167-R181.
231. Kim, K. H.; Kim, M. J.; Choa, Y. H.; Kim, D. H.; Yu, J. H. Synthesis and magnetic properties of surface coated magnetite superparamagentic nanoparticles. Magn. IEEET 2008, 44, 2940-2943.
232. Mahjoob, S.; Vafai, K. Analytical characterization of heat transport through biological media incorporating hyperthermia treatment. Int. J. Heat Mass Tran. 2009, 52, 1608-1618.
233. Johannsen, M.; Gneveckow, U.; Thiesen, B.; Taymoorian, K.; Cho, C. H.; Waldofner, N.; Scholz, R.; Jordan, A.; Loening, S. A.; Wust, P. Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three-dimensional temperature distribution. Eur. Urol. 2007, 52, 1653-1661.
234. Mitsumori, M.; Hiraoka, M.; Shibata, T.; Okuno, Y.; Nagata, Y.; Nishimura, Y.; Abe, M.; Hasegawa, M.; Nagae, H.; Ebisawa, Y. Targeted hyperthermia using dextran magnetite complex: a new treatment modality for liver tumors. Hepatogastroenterology 1996, 43, 1431-1437.
235. Hilger, I.; Hergt, R.; Kaiser, W. A. Towards breast cancer treatment by magnetic heating. J. Magn. Magn. Mater. 2005, 293, 314-319.
236. Gobin, A. M.; Lee, M. H.; Halas, N. J.; James, W. D.; Drezek, R. A.; West, J. L. Near-infrared resonant nanoshells for combined optical imaging and photothermal cancer therapy. Nano Lett. 2007, 7, 1929-1934.
237. Bardhan, R.; Grady, N. K.; Cole, J. R.; Joshi, A.; Halas, N. J. Fluorescence enhancement by Au nanostructures: nanoshells and nanorods. ACS Nano. 2009, 3, 744-752.